Market Place
Sourcing Support
Daiichi Sankyo`s Biologic Datroway Receives Approval in US
17 Jan 2025 //
FDA
Biocon`s Generics Dasatinib Receive Tentative Approval in US
17 Jan 2025 //
FDA
Pfizer`s Biologic Elelyso Receives Suppl Approval in US
17 Jan 2025 //
FDA
Amneal`s Generics Rifaximin Receive Tentative Approval in US
16 Jan 2025 //
FDA
Dr. Reddy`s Generics Sitagliptin Receive Tentative Approval in US
16 Jan 2025 //
FDA
Caplin`s Generics Levetiracetam Receives Approval in US
16 Jan 2025 //
FDA
Eli lilly`s Biologic Omvoh Receives Suppl Approval in US
15 Jan 2025 //
FDA
Rubicon`s Generics Ipratropium Br Receives Approval in US
14 Jan 2025 //
FDA
Ascent Pharma`s Generics Carbidopa, Levodopa Receives Approval in US
14 Jan 2025 //
FDA
Alkem Lab`s Generics Carbamazepine Receives Approval in US
14 Jan 2025 //
FDA
Riconpharma`s Generics Mesna Receives Approval in US
14 Jan 2025 //
FDA
Amneal Pharma`s Generics Everolimus Receives Approval in US
10 Jan 2025 //
FDA
MSN Lab`s Generics Perampanel Receive Tentative Approval in US
08 Jan 2025 //
FDA
Apotex`s Generics Mirabegron Receives Approval in US
08 Jan 2025 //
FDA
Macleods`s Generics Valsartan, HCTZ Receives Approval in US
07 Jan 2025 //
FDA
Torrent`s Generics Dimethyl Fumarate Receives Approval in US
06 Jan 2025 //
FDA
Novartis`s Fabhalta Receives Approval in Canada
06 Jan 2025 //
HEALTH CANADA
ScinoPharm`s Generics Clofarabine Receives Approval in US
03 Jan 2025 //
FDA
Cipla`s Generics Phytonadione Receives Approval in US
03 Jan 2025 //
FDA
Teva`s Generics Elagolix Receive Tentative Approval in US
02 Jan 2025 //
FDA
Ascent Pharma`s Generics Lubiprostone Receives Approval in US
02 Jan 2025 //
FDA
Genzyme`s Biologic Lumizyme Receives Suppl Approval in US
30 Dec 2024 //
FDA
BeiGene`s Biologic Tevimbra Receives Approval in US
30 Dec 2024 //
FDA
BMS`s Biologic Opdivo Qvantig Receives Approval in US
27 Dec 2024 //
FDA
Rubicon`s Generics Bumetanide Receives Approval in US
27 Dec 2024 //
FDA
Ridgeback`s Biologic Ebanga Receives Suppl Approval in US
26 Dec 2024 //
FDA
Aurobindo`s Generics Deutetrabenazine Receives Approval in US
26 Dec 2024 //
FDA
Novo Nordisk`s Biologic Alhemo Receives Approval in US
20 Dec 2024 //
FDA
Alembic`s Generics Divalproex Sodium Receives Approval in US
19 Dec 2024 //
FDA
Amgen`s Biologic Kanjinti Receives Suppl Approval in US
19 Dec 2024 //
FDA
Hikma`s Generics Phytonadione Receives Approval in US
19 Dec 2024 //
FDA
Genzyme`s Biologic Cerezyme Receives Suppl Approval in US
19 Dec 2024 //
FDA
Celltrion`s Biologic Stqeyma Receives Suppl Approval in US
17 Dec 2024 //
FDA
Granules`s Generics Lisdexamfetamine Receives Approval in US
16 Dec 2024 //
FDA
MSN Lab`s Generics Perampanel Receives Tentative Approval in US
16 Dec 2024 //
FDA
Galderma`s Biologic Nemluvio Receives Approval in US
13 Dec 2024 //
FDA
Mylan`s Generics Glucagon Receives Approval in US
12 Dec 2024 //
FDA
Merck`s Biologic Keytruda Receives Suppl Approval in US
11 Dec 2024 //
FDA
Gland Pharma`s Generics Phytonadione Receives Approval in US
10 Dec 2024 //
FDA
Thinq Pharma`s Generics Chlorpromazine HCl Receives Approval in US
10 Dec 2024 //
FDA
Cipla`s Generics Eliglustat Tartrate Receives Approval in US
10 Dec 2024 //
FDA
Sciegen`s Generics Ezetimibe & Simvastatin Receives Approval in US
10 Dec 2024 //
FDA
Myerus`s Biologic Bizengri Receives Approval in US
04 Dec 2024 //
FDA
AstraZeneca`s Biologic Imfinzi Receives Suppl Approval in US
04 Dec 2024 //
FDA
Amneal`s Generics Doxycycline Hyclate Receives Approval in US
04 Dec 2024 //
FDA
Astellas Pharma`s Veozah Receives Approval in Canada
03 Dec 2024 //
HEALTH CANADA
SIFI SpA`s Akantior Receives Approval in Europe
29 Nov 2024 //
EMA
Mylan Pharma`s Biologic Semglee Receives Suppl Approval in US
25 Nov 2024 //
FDA
Macleods`s Generics Apremilast Receives Approval in US
25 Nov 2024 //
FDA
Hibrow`s Generics Hydrocortisone Receives Approval in US
25 Nov 2024 //
FDA
Janseen`s Biologic Tecvayli Receives Suppl Approval in US
22 Nov 2024 //
FDA
Genentech`s Biologic Lunsumio Receives Suppl Approval in US
22 Nov 2024 //
FDA
Jazz Pharma`s Biologic Ziihera Receives Approval in US
20 Nov 2024 //
FDA
Qilu Pharma`s Generics Icosapent Ethyl Receives Approval in US
20 Nov 2024 //
FDA
Mylan`s Generics Sugammadex Receives Tentative Approval in US
20 Nov 2024 //
FDA
Amgen`s Biologic Repatha Receives Suppl Approval in US
20 Nov 2024 //
FDA
Merck Sharp`s Biologic Keytruda Receives Suppl Approval in US
20 Nov 2024 //
FDA
Regeneron`s Ordspono Receives Approval in Europe
19 Nov 2024 //
EMA
Aspiro Pharma`s Generics Chlorpromazine HCl Receives Approval in US
18 Nov 2024 //
FDA
Samsung Bioepis`s Biologic Epysqli Receives Suppl Approval in US
15 Nov 2024 //
FDA
